Namshik Han
About
Group Leader, Milner Therapeutics Institute
CRISPR experiment
Drug screening
PK/PD experiment
Tox screening
Namshik Han aims to develop new Artificial Intelligence approaches and to facilitate access of partner pharma/biotech companies to cutting-edge computational technology fulfilling the global mission of identifying new or better therapies from the analysis of biomedical big data. Learn more.
Research Areas Therapeutic target discovery across disease Personalised medicine Drug efficacy and safety Drug positioning/ repositioning Biomarker discovery Techniques Artifical Intelligence Computational biology Multi-omics analysis Network analysis NLP and text mining Areas for Collaboration Omics data generation
CRISPR experiment
Drug screening
PK/PD experiment
Tox screening
Research Theme